Efficacy and safety of stapokibart in adolescents with moderate-to-severe atopic dermatitis: a multicentre randomized double-blind placebo-controlled phase III trial

Post time The day before yesterday 19:56

journal：British Journal of Dermatology

Authors：Cheng Zhou; Yan Zhao; Guannan Zhu; Liming Wu; Yi Liu; Xiaohua Tao; Hengguang Zhao; Zhu Wei; Wei Lu; Weiquan Li; Yangfeng Ding; Xiaohong Zhu; Guohong Hu; Hao Cheng; Rong Xiao; Xiao-Yong Man; Qi Wang; Shanshan Li; Tongxiang Zeng; Lihua Wang; Yufeng Xu; Libo Zhang; Wei Liu; Guoqing Zhao; Yingmin Jia; Yanqiu Huang; Bo Chen; Jianzhong Zhang

Published date：2026-5-19

DOI：10.1093/bjd/ljag052

PDF link：https://academic.oup.com/bjd/adv ... 6938126/ljag052.pdf

Article link：https://doi.org/10.1093/bjd/ljag052

Article Source：Oxford University Press (OUP)。

Remark：

Post time The day before yesterday 20:21

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

[Oxford] Efficacy and safety of stapokibart in adolescents with moderate-to-severe atopic dermatitis: a multicentre randomized double-blind placebo-controlled phase III trial

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Oxford] Efficacy and safety of stapokibart in adolescents with moderate-to-severe atopic dermatitis: a multicentre randomized double-blind placebo-controlled phase III trial Copy

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Oxford] Efficacy and safety of stapokibart in adolescents with moderate-to-severe atopic dermatitis: a multicentre randomized double-blind placebo-controlled phase III trial